Bessemer Group’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Other funds holding GH
DTC
Bessemer Group's GH Position: Q2 2026 in Review
Bessemer Group increased its Guardant Health (GH) stake by 22% in Q2 2026, buying an estimated $3.37K and bringing the position to 169 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #1905.
Bessemer Group first reported a position in GH in Q3 2021 and has held it in 10 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.
- Bessemer Group held 169 shares of Guardant Health worth $26K as of Q2 2026.
- Bessemer Group bought 31 Guardant Health shares in Q2 2026, an estimated $3.37K.
- Guardant Health made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #1905 holding.
- Bessemer Group first reported a position in Guardant Health in Q3 2021 and has held it in 10 quarters since.
- 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.
Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.